U.S. Pharmacist Weekly News Update
August 15, 2018

Longer Influenza Virus Shedding Linked to Obesity, Increases Transmission
Here’s another good reason pharmacists should urge people to adopt a healthier lifestyle by both losing weight and getting annual influenza vaccines: Those who are older and obese have longer flu-virus shedding periods when they have the flu, putting others at risk, a new study has found. How much is the risk increased?


Adult ADHD Patients Adhere Better to Monotherapy Than Combination Treatment
When pharmacists notice concurrent prescriptions for high-dose opioids combined with benzodiazepine sedatives, they should raise concerns. That is one of the actions that could help save lives, according to a new study. Here are more details.

Protease Inhibitors Increase CV Risks in HIV Patients With Heart Failure
Pharmacists might want to raise a red flag when they see a prescription for ritonavir-boosted protease inhibitors in patients with both HIV and heart failure. Recent research linked worsening heart failure and greater risk of cardiovascular death when that treatment is used in those patients. Find out more.

FDA Warns About Azithromycin for Post-Stem Cell Transplant Lung Condition
Azithromycin should never be prescribed long-term to prevent a common lung issue following stem-cell transplant for cancer. That’s according to the FDA, which issued a drug safety communication and urged manufacturers to send out a “Dear Health Care Provider” letter. What prompted the actions?


Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App